Literature DB >> 19040412

Ten-year quality control of a semiautomated procedure of cord blood unit volume reduction.

Lucilla Lecchi1, Lucia Perego, Filomena Garcea, Ilaria Ratti, Manuela Brasca, Deborah Dotti, Silvia Cimoni, Ilaria Pezzali, Teresa Celeste, Silvia Giovanelli, Barbara Butti, Nicola De Fazio, Raffaella Lopa, Paolo Rebulla.   

Abstract

BACKGROUND: Volume reduction of cord blood units decreases the cost of cryogenic storage. This study reports the analysis of a 10-year quality control program of a semiautomated cord blood volume reduction procedure. STUDY DESIGN AND METHODS: Cord blood was collected in a plastic bag containing 29 mL citrate-phosphate-dextrose, centrifuged at 2124 x g for 12 minutes, and processed with a semiautomated device. The procedure was aimed at removing most red blood cells and plasma and concentrating hematopoietic progenitors in the buffy coat (BC), thus reducing the unit volume and saving cryogenic space. Finally, the BC was cryopreserved with an equal volume of 20 percent dimethyl sulfoxide. Total nucleated cells (TNCs) were counted before and after processing in the 4311 units banked from 1998 through 2007, whereas CD34+ cells and colony-forming units-granulocyte-macrophage (CFU-GM) were counted in 420 random units from 2001 through 2007.
RESULTS: Mean postvolume reduction annual recoveries of TNCs, CD34+ cells, and CFU-GM ranged from 82.8 +/- 12.3 (standard deviation) to 91.4 +/- 6.4 percent, from 87.8 +/- 14.1 to 95.2 +/- 23.8 percent, and from 101.5 +/- 51.4 to 117.8 +/- 59.5 percent, respectively. Very strong correlations were found (r > 0.87) between postprocessing versus preprocessing TNCs, CD34+ cells, and CFU-GM; a moderate correlation between initial TNC count and unit's volume (r = 0.51); and no correlation between TNC percentage of recovery in the BC and initial unit's volume. The latter data indicate that most TNCs concentrate in the BC.
CONCLUSIONS: The semiautomated procedure of cord blood unit volume reduction used in this study provides high and stable cellular recoveries during several years of routine cord blood banking.

Entities:  

Mesh:

Year:  2008        PMID: 19040412     DOI: 10.1111/j.1537-2995.2008.02013.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  5 in total

1.  Mononuclear cells from a rare blood donor, after freezing under good manufacturing practice conditions, generate red blood cells that recapitulate the rare blood phenotype.

Authors:  Francesca Masiello; Valentina Tirelli; Massimo Sanchez; Emile van den Akker; Girelli Gabriella; Maurizio Marconi; Maria Antonietta Villa; Paolo Rebulla; Ghazala Hashmi; Carolyn Whitsett; Anna Rita Migliaccio
Journal:  Transfusion       Date:  2013-09-04       Impact factor: 3.157

2.  Cord Blood Banking and Transplantation in China: A Ten Years Experience of a Single Public Bank.

Authors:  Jinhui Liu; Ji He; Shu Chen; Fei Qin; Fang Wang; Gang Xu; Faming Zhu; Hangjun Lv; Lixing Yan
Journal:  Transfus Med Hemother       Date:  2011-12-27       Impact factor: 3.747

3.  The Royan Public Umbilical Cord Blood Bank: Does It Cover All Ethnic Groups in Iran Based on HLA Diversity?

Authors:  Saeideh Ebrahimkhani; Shirin Farjadian; Marzieh Ebrahimi
Journal:  Transfus Med Hemother       Date:  2014-02-17       Impact factor: 3.747

4.  Qualitative and quantitative cell recovery in umbilical cord blood processed by two automated devices in routine cord blood banking: a comparative study.

Authors:  Pilar Solves; Dolores Planelles; Vicente Mirabet; Amando Blanquer; Francisco Carbonell-Uberos
Journal:  Blood Transfus       Date:  2012-09-12       Impact factor: 3.443

5.  Clinical-grade generation of active NK cells from cord blood hematopoietic progenitor cells for immunotherapy using a closed-system culture process.

Authors:  Jan Spanholtz; Frank Preijers; Marleen Tordoir; Carel Trilsbeek; Jos Paardekooper; Theo de Witte; Nicolaas Schaap; Harry Dolstra
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.